Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes
Cusi K, Cukier S, DeFronzo RA, Torres M, Puchulu FM, Redondo JC
Published in Journal of Clinical Endocrinology and Metabolism
Methodology
Six-week open trial of vanadyl sulfate 50 mg twice daily with euglycemic clamp studies in patients with type 2 diabetes.
Key Findings
Vanadyl sulfate modestly improved hepatic and skeletal muscle insulin sensitivity and lowered fasting glucose and HbA1c, with frequent gastrointestinal side effects.
Conclusions
Vanadyl sulfate has measurable insulin-sensitising effects in type 2 diabetes but the magnitude is small relative to established therapies.
Limitations
Small sample, no placebo group, short duration, gastrointestinal intolerance common.
Supplements Studied
Vanadyl sulfate improved hepatic and muscle insulin sensitivity in patients with type 2 diabetes.
Outcomes Measured
Vanadyl sulfate modestly improved hepatic and skeletal muscle insulin sensitivity and lowered fasting glucose and HbA1c, with frequent gastrointestinal side effects.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.